These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection]. Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738 [TBL] [Abstract][Full Text] [Related]
3. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2. Juliao Caamaño DS; Alonso Beato R J Clin Neurosci; 2020 Jul; 77():230-232. PubMed ID: 32410788 [TBL] [Abstract][Full Text] [Related]
4. [Bifacial weakness with paresthesia – a rare Guillain–Barré syndrome subtype associated with SARS-CoV-2 infection]. Gaál T; Szeszák G; Torák G; Salacz P Orv Hetil; 2021 Nov; 162(45):1803-1807. PubMed ID: 34747359 [TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome with bilateral facial diplegia secondary to severe acute respiratory syndrome coronavirus-2 infection: a case report. Ramirez N; Ujueta D; Diaz LF; Folleco LE; Rodríguez A; Gaona I; Nava-Mesa MO J Med Case Rep; 2021 Nov; 15(1):558. PubMed ID: 34782002 [TBL] [Abstract][Full Text] [Related]
6. Facial Diplegia Variant of Guillain-Barré Syndrome in Pregnancy Following COVID-19 Vaccination: A Case Report. Zubair AS; Bae JY; Desai K Cureus; 2022 Feb; 14(2):e22341. PubMed ID: 35371813 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome. Finsterer J; Matovu D; Scorza FA Clinics (Sao Paulo); 2022; 77():100064. PubMed ID: 35751951 [TBL] [Abstract][Full Text] [Related]
15. Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series. Kaulen LD; Doubrovinskaia S; Mooshage C; Jordan B; Purrucker J; Haubner C; Seliger C; Lorenz HM; Nagel S; Wildemann B; Bendszus M; Wick W; Schönenberger S Eur J Neurol; 2022 Feb; 29(2):555-563. PubMed ID: 34668274 [TBL] [Abstract][Full Text] [Related]
16. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome? Zheng X; Fang Y; Song Y; Liu S; Liu K; Zhu J; Wu X Eur J Med Res; 2023 Feb; 28(1):98. PubMed ID: 36841799 [TBL] [Abstract][Full Text] [Related]
17. Guillain-Barré syndrome presenting with facial diplegia following COVID-19 vaccination in two patients. Kanabar G; Wilkinson P BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34649856 [TBL] [Abstract][Full Text] [Related]
18. Loss of Taste as an Initial Symptom of a "Facial Diplegia and Paresthesia" Variant of Guillain-Barré Syndrome. Hiraga A; Muto M; Kuwabara S Intern Med; 2022 Oct; 61(19):2957-2959. PubMed ID: 35908975 [TBL] [Abstract][Full Text] [Related]
19. Facial Diplegia as a Rare Late Neurologic Manifestation of SARS-CoV-2 Infection. Judge C; Moheb N; Castro Apolo R; Dupont JL; Gessner ML; Yacoub HA J Neurol Res; 2020 Dec; 10(6):235-236. PubMed ID: 33984099 [TBL] [Abstract][Full Text] [Related]
20. Facial Diplegia-Complication or Manifestation of SARS-CoV-2 Infection? A Case Report and Systemic Literature Review. Szewczyk AK; Skrobas U; Jamroz-Wiśniewska A; Mitosek-Szewczyk K; Rejdak K Healthcare (Basel); 2021 Nov; 9(11):. PubMed ID: 34828542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]